| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Drug safety: can more be done?
|
|
|
2013
|
9 |
2 |
p. 71-73
|
artikel
|
| 2 |
Drug safety regulations and strategies of the German authority for medicinal products
|
Beckmann, Jürgen
|
|
2013
|
9 |
2 |
p. 75-81
|
artikel
|
| 3 |
Drug safety regulations in the CPMP
|
Lee, Richard
|
|
2013
|
9 |
2 |
p. 107-113
|
artikel
|
| 4 |
Drug safety regulations of the ‘Drug Commission of the Counties’
|
Amschler, U.
|
|
2013
|
9 |
2 |
p. 91-93
|
artikel
|
| 5 |
Drug safety regulations of the ‘Drug Commission of the German Pharmacists’
|
Dinnendahl, V.
|
|
2013
|
9 |
2 |
p. 87-90
|
artikel
|
| 6 |
Drug safety regulations of the‘Drug Commission of the German Physicians’
|
Munter, K.-H.
|
|
2013
|
9 |
2 |
p. 83-86
|
artikel
|
| 7 |
Safety and risk in practice
|
Tempelaar, André F.
|
|
2013
|
9 |
2 |
p. 121-129
|
artikel
|
| 8 |
Statutory regulations governing the reporting of adverse reactions
|
Bertelsmann, Annekarin
|
|
2013
|
9 |
2 |
p. 101-106
|
artikel
|
| 9 |
The German ‘Graduated Plan’ – criteria, administration, regulations
|
Thiele, A.
|
|
2013
|
9 |
2 |
p. 95-100
|
artikel
|
| 10 |
The monitoring of drug safety and reporting of adverse drug reactions
|
Bankowski, Zbigniew
|
|
2013
|
9 |
2 |
p. 115-120
|
artikel
|
Tijdschrift beschrijving